Skip to main content
. 2021 Apr 14;47(5):538–548. doi: 10.1007/s00134-021-06388-0

Table 2.

Characteristics and outcomes of critically ill patients stratified by advanced respiratory support

Characteristics Total
n = 4,188
NIRS only
n = 1,558
NIRS failure
n = 865
IMV
n = 1,765
Age, median (IQR) 63 (49, 76) 55 (43, 67) 65 (53, 77) 68 (54, 80)
  < 40 482 (12%) 286 (18%) 65 (7.5%) 131 (7.4%)
 40–49 601 (14%) 307 (20%) 105 (12%) 189 (11%)
 50–59 779 (19%) 376 (24%) 143 (17%) 260 (15%)
 60–69 840 (20%) 270 (17%) 227 (26%) 343 (19%)
 70–79 696 (17%) 162 (10%) 143 (17%) 391 (22%)
  ≥ 80 790 (19%) 157 (10%) 182 (21%) 451 (26%)
Sex, No. (%)
 Female 1516 (36%) 546 (35%) 305 (35%) 665 (38%)
 Male 2672 (64%) 1012 (65%) 560 (65%) 1100 (62%)
Admissions from emergency department 2848 (68%) 1244 (80%) 581 (67%) 1023 (58%)
Modified Frailty Index (MFI)
 Non-frail (MFI = 0) 1164 (28%) 617 (40%) 199 (23%) 348 (20%)
 Pre-frail (MFI = 1–2) 2128 (51%) 732 (47%) 459 (53%) 937 (53%)
 Frail (MFI >  = 3) 896 (21%) 209 (13%) 207 (24%) 480 (27%)
SAPS-3, median (IQR) 50 (42, 61) 43 (39, 51) 54 (45, 66) 55 (46, 67)
  ≤ 42 1,165 (28%) 727 (47%) 147 (17%) 291 (16%)
 43–50 982 (23%) 434 (28%) 198 (23%) 350 (20%)
 51–61 1,034 (25%) 276 (18%) 242 (28%) 516 (29%)
  > 61 1,007 (24%) 121 (7.8%) 278 (32%) 608 (34%)
SOFA, median (IQR) 2 (0, 5) 1 (0, 2) 3 (1, 7) 4 (1, 8)
Any comorbidities, No. (%) 3393 (81%) 1111 (71%) 754 (87%) 1528 (87%)
PaO2 /FiO2 [ n = 1,963] 170 (94, 279) 216 (89, 329) 142 (90, 233) 172 (101, 273)
 Normal (> 300) 431 (22%) 139 (32%) 75 (15%) 217 (21%)
 Mild (201–300) 385 (20%) 89 (21%) 91 (18%) 205 (20%)
 Moderate (101–200) 621 (32%) 78 (18%) 191 (38%) 352 (34%)
 Severe (≤ 100) 526 (27%) 125 (29%) 146 (29%) 255 (25%)
Non-invasive respiratory support
 Only NPPV 2061 (85%) 1356 (87%) 705 (82%) -
 Only HFNC 136 (5.6%) 87 (5.6%) 49 (5.7%) -
 Both 226 (9.3%) 115 (7.4%) 111 (13%) -
Vasopressor, No. (%) 1890 (45%) 60 (3.9%) 672 (78%) 1158 (66%)
Renal replacement therapy, No. (%) 896 (21%) 24 (1.5%) 278 (32%) 594 (34%)
Length-of-stay (LOS), median (IQR)
 ICU [ n = 4,185] 12 (7, 22) 8 (4, 11) 19 (12, 27) 16 (9, 27)
 Hospital [ n = 4,160] 17 (10, 30) 11 (8, 16) 24 (16, 38) 22 (12, 38)
Hospitalizations with LOS > 7 days
 ICU [ n = 4,185] 3011 (72%) 788 (51%) 787 (91%) 1436 (81%)
 Hospital [ n = 4,160] 3496 (84%) 1166 (75%) 804 (94%) 1526 (87%)
Period 1 (February 27th to April 25th) 727 (17%) 84 (5.4%) 98 (11%) 545 (31%)
Period 2 (April 26th to June 6th) 1264 (30%) 308 (20%) 259 (30%) 697 (39%)
Period 3 (June 7th to August 10th) 1058 (25%) 513 (33%) 259 (30%) 286 (16%)
Period 4 (August 11th to October 28th) 1139 (27%) 653 (42%) 249 (29%) 237 (13%)
60-day in-hospital deaths, No. (%) 1544 (37%) 72 (4.6%) 444 (51%) 1028 (58%)
ICU deaths, No. (%) [ n = 13,294] 1329 (32%) 47 (3.0%) 398 (46%) 884 (50%)
In-hospital deaths, No. (%) [ n= 13,219] 1572 (38%) 73 (4.7%) 457 (53%) 1042 (59%)

SD—standard deviation; IQR—interquartile range; SAPS—Simplified Acute Physiology Score; SOFA—Sequential Organ Failure Assessment; NIRS—non-invasive respiratory support; NPPV—non-invasive positive pressure ventilation; HFNC—high-flow nasal cannula; IMV—invasive mechanical ventilation; ICU—intensive care unit.